b3galt6 knock-out zebrafish recapitulate β3GalT6-deficiency disorders in human and reveal a trisaccharide proteoglycan linkage region

0 views • Oct 30, 2021
0
Save
Cite
Share

Author(s)

Author Name

Sarah Delbaere

Published 1 Project

Genetics

Adelbert De Clercq

Published 1 Project

Genetics

Shuji Mizumoto

Published 1 Project

Genetics

Fredrik Noborn

Published 2 Projects

Genetics Cell Biology

Jan Willem Bek

Published 1 Project

Genetics

Lien Alluyn

Published 1 Project

Genetics

Charlotte Gistelinck

Published 1 Project

Genetics

Delfien Syx

Published 1 Project

Genetics

Phil L. Salmon

Published 1 Project

Genetics

Paul Coucke

Published 1 Project

Genetics

Uploader

Göran Larson

Shuhei Yamada

Published 1 Project

Genetics

Andy Willaert

Published 1 Project

Genetics

Fransiska Malfait

Published 1 Project

Genetics

Add New Author

Proteoglycans are structurally and functionally diverse biomacromolecules found abundantly on cell membranes and in the extracellular matrix. They consist of a core protein linked to glycosaminoglycan chains via a tetrasaccharide linkage region. Here, we show that CRISPR/Cas9-mediated b3galt6 knock-out zebrafish, lacking galactosyltransferase II, which adds the third sugar in the linkage region, largely recapitulate the phenotypic abnormalities seen in human β3GalT6-deficiency disorders. These comprise craniofacial dysmorphism, generalized skeletal dysplasia, skin involvement and indications for muscle hypotonia. In-depth TEM analysis revealed disturbed collagen fibril organization as the most consistent ultrastructural characteristic throughout different affected tissues. Strikingly, despite a strong reduction in glycosaminoglycan content, as demonstrated by anion-exchange HPLC, subsequent LC-MS/MS analysis revealed a small amount of proteoglycans containing a unique linkage region consisting of only three sugars. This implies that formation of glycosaminoglycans with an immature linkage region is possible in a pathogenic context. Our study therefore unveils a novel rescue mechanism for proteoglycan production in the absence of galactosyltransferase II, hereby opening new avenues for therapeutic intervention. ### Competing Interest Statement The authors have declared no competing interest.

Genetics
Genetics 59 Projects